Tagged Articles

Risperdal lawsuits 17 articles

J&J unfazed by growing number of Risperdal lawsuits

Lawsuits pending in a mass tort in Pennsylvania involving disfiguring side effects allegedly caused by the antipsychotic drug Risperdal have grown by nearly 40 percent from 2015, and the number is expected to climb higher. The thousands of people suing Risperdal makers Johnson & Johnson and its subsidiary Janssen Pharmaceuticals claim the drug company knew Risperdal could cause adolescent boys to grow female-like breasts, but failed to warn consumers or their doctors. The drug companies have already lost a handful of trials totaling about $75 million in verdicts, one of which was a $70 million verdict in favor of a Tennessee ... Read More

Janssen wants fact sheets on plaintiffs suing over Risperdal side effects

Johnson & Johnson’s subsidiary Janssen Pharmaceuticals wants new plaintiffs in the Risperdal mass tort to include plaintiffs fact sheets detailing prescription records and documentation of gynecomastia diagnoses allegedly caused by the company’s antipsychotic drug Risperdal. Janssen claims that the information will help weed out any claims without merit, but those suing the drug company argue that the requirement would create a “pseudo-summary judgment” and kick out cases that deserve to be heard. Janssen first pushed for the fact sheets in January after a 39 percent surge in new cases in the mass tort during 2016. Recent court statistics show 1,945 ... Read More

Man says he is scarred by Risperdal side effects

When Eddie Bible was a young teenager, he became a recluse. The stares and comments he got from his classmates was unbearable. “I had bigger boobs than the girls in school,” he said. “I thought, ‘Am I going to have to get a training bra?’” Bible, now 26, was prescribed the antipsychotic Risperdal in the early 2000s to treat anxiety and bipolar disorder. He didn’t know at the time that the medication was triggering his body to produce prolactin, the hormone that causes breast growth and lactation in pregnant women. “If I knew what the side effects would be of ... Read More

Lawyers lose fight to pull Risperdal from market over safety risks

A Philadelphia-based law firm representing boys who allege they were disfigured after taking Johnson & Johnson’s Janssen Pharmaceutical’s antipsychotic drug Risperdal has no standing to challenge the Food and Drug Administration’s (FDA) denial of a citizen’s petition asking the agency to revoke marketing approval for the drug until its long-term safety can be proven. The attorneys also asked the companies to hand over confidential documents describing the risks associated with the drug. The firm had argued that the FDA’s rejection of its citizen petition, which was filed in July 2012, led to increased cost from Risperdal-related personal injury lawsuits against ... Read More

Plaintiffs attorney fights statute of limitations for Risperdal claims

A litigation-wide cutoff date established by a trial judge for claims made against Johnson & Johnson’s Janssen Pharmaceuticals over Risperdal side effects does not apply standard discovery-rule principles and unfairly places hundreds of cases at risk of dismissal, an attorney representing hundreds of plaintiffs told a Pennsylvania Superior Court. The issue directly affects about 275 cases that have been dismissed due to Supervising Judge Arnold New’s stated statute of limitations for Risperdal lawsuits. The three-judge panel heard several issues on appeal involving claims that Janssen’s antipsychotic drug Risperdal caused adolescent boys to develop female breasts, a condition known as gynecomastia. One ... Read More

Judge adds $6.66 million to landmark $70 million Risperdal award

A Pennsylvania state judge tacked on an additional $6.66 million to the landmark $70 million judgment against Johnson & Johnson and its subsidiary Janssen Pharmaceuticals over allegations that the companies’ antipsychotic drug Risperdal caused a Tennessee adolescent boy to grow female breasts. Plaintiffs attorneys asked Philadelphia County Court of Common Pleas Judge Paula A. Patrick to increase the award amount after the verdict was issued, arguing the family was entitled to delay damages from April 16, 2014, which is one year after the complaint was filed, to July 1, 2016, the date when the verdict was handed down. Attorneys for ... Read More

Young man files Risperdal lawsuit after growing female breasts

Shaquil Byrd’s childhood was difficult enough, with a mental condition that required antipsychotic medication. At age 10, things got increasingly worse when he grew female breasts. He dealt with constant teasing from his classmates. “I was going to war to protect myself from the things people would say to me,” he said. His mother, Eugenia Jordan, says her son’s tender and lactating breasts robbed him of a normal childhood. “He did a lot of crying. He was very uncomfortable around other people,” she said. When she and Shaquil, now 22, learned that his condition, called gynecomastia, was possibly caused by ... Read More

Record-setting $70 million Risperdal side effects verdict a win for ‘the little guy’

The $70 million a Philadelphia jury awarded a young Tennessee man allegedly disfigured by the antipsychotic drug Risperdal was not only unprecedented, ringing in 28 times higher than the highest jury verdict previously decided in similar lawsuits involving the drug, it serves as proof that sometimes the little guy wins, said the father of the plaintiff. “We are glad that Andrew’s suffering now stands for something,” Plaintiff Andrew Yount’s father, Terry Yount, told the Pennsylvania Record. “We hope this verdict gives hope to the thousands of other boys who were disfigured by Risperdal that they will get justice too. We’re ... Read More

Johnson & Johnson ordered to compensate victims of Risperdal-induced gynecomastia

Johnson & Johnson suffered a significant blow last week when a Philadelphia jury slapped the consumer health care giant with a $70 million judgment over claims that its antipsychotic drug Risperdal caused an adolescent boy to grow female breasts. “The cases are not going away, and as the losses mount, J&J must also deal with its image, which has been tarnished from this ongoing saga,” BioPharma Dive reported. “To make matters worse, J&J is also facing numerous lawsuits alleging a link between the company’s talcum powder and ovarian cancer.” The company has already been slapped with back-to-back judgments in those ... Read More

$2.5 million verdict over Risperdal side effects stands

A $2.5 million jury verdict against Johnson & Johnson’s Janssen Pharmaceuticals involving claims the company’s antipsychotic drug Risperdal caused an autistic boy to grow female breasts will stand, a Philadelphia judge ruled. Philadelphia County Court of Common Pleas Judge Ramy I. Djerassi rejected the drug company’s bid for a new trial based on claims that allowing a new expert in the bellwether trial had left Janssen’s attorneys unprepared for the new testimony. The drug company also argued that the $2.5 million verdict was excessive because it relied on the plaintiff’s mother’s accounts of her son’s experiences after growing breasts. Djerassi ... Read More